You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 40 No. 3, March 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (70)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Long v Short Half-life Benzodiazepines in the Elderly

Kinetics and Clinical Effects of Diazepam and Oxazepam

Carl Salzman, MD; Richard I. Shader, MD; David J. Greenblatt, MD; Jerold S. Harmatz

Arch Gen Psychiatry. 1983;40(3):293-297.


Abstract



• Oxazepam and diazepam were compared in healthy elderly volunteers. Absorption of diazepam was faster than oxazepam and onset of clinical effects were more profound. Diazepam accumulation was extensive, washout was slow and active compounds were present two weeks after the last dose. Oxazepam accumulation was significantly less and elimination significantly faster than diazepam. There was no difference between oxazepam and diazepam in sedation or fatigue during the drug treatment, but sedative effects persisted for two weeks after diazepam therapy was discontinued. Sedation rapidly returned to baseline in the oxazepam group. Thus, the differing pharmacokinetic profiles of diazepam and oxazepam have clinical consequences during multiple dosage in the elderly.



Author Affiliations



From the Psychopharmacology Research Laboratory, Harvard Medical School and Massachusetts Mental Health Center (Dr Salzman), and the Department of Psychiatry (Dr Shader and Mr Harmatz) and the Division of Clinical Pharmacology (Dr Greenblatt), Tufts University School of Medicine and the New England Medical Center Hospital, Boston.


Footnotes



Accepted for publication March 12, 1982.

Reprint requests to Clinical Psychopharmacology Service, Massachusetts Mental Health Center, 74 Fenwood Rd, Boston, MA 02115 (Dr Salzman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine
Rowan et al.
Neurology 2005;64:1868-1873.
ABSTRACT | FULL TEXT  

Medications and the Safety of the Older Driver: Is There a Basis for Concern?
Ray et al.
Human Factors: The Journal of the Human Factors and Ergonomics Society 1992;34:33-47.
ABSTRACT  

Benzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray et al.
JAMA 1989;262:3303-3307.
ABSTRACT  

Differences in Diazepam and Oxazepam
DeVane and Stewart
Arch Gen Psychiatry 1984;41:311-311.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.